Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologistxxxs Decision on Systemic Therapy in a Real-World Setting

R Erber, M Angeloni, R Stohr, MP Lux, D Ulbrich-Gebauer, E Pelz, A Bankfalvi, KW Schmid, RFH Walter, M Vetter, C Thomssen, D Mayr, F Klauschen, P Sinn, Karl Sotlar (Co-author), K Stering, A Stenzinger, M Wunderle, PA Fasching, MW BeckmannO Hoffmann, R Kimmig, N Harbeck, R Wuerstlein, F Ferrazzi, A Hartmann

Research output: Contribution to journalOriginal Articlepeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)8716
JournalINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume23
Issue number15
DOIs
Publication statusPublished - 2022

Keywords

  • LATE DISTANT RECURRENCE
  • AMERICAN SOCIETY
  • GENE-EXPRESSION
  • ADJUVANT CHEMOTHERAPY
  • PAM50 RISK
  • POSTMENOPAUSAL WOMEN
  • INTERNATIONAL KI67
  • ENDOCRINE THERAPY
  • GUIDE DECISIONS
  • SCORE

Cite this